503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518824


Varnish cache server

4-Traders Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Getinge AB    GETI B   SE0000202624

GETINGE AB (GETI B)

503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518826


Varnish cache server

14
503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518828


Varnish cache server

04/21 GETINGE : launches the new Advanta V12 - 32mm Balloon Expandable Cov..
04/20 GETINGE : Chief Financial Officer leaves Getinge
04/18 MEDTRONIC : Extracorporeal Membrane Oxygenation (ECMO) Systems Marke..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518830


Varnish cache server

Getinge : launches the new Advanta V12 - 32mm Balloon Expandable Covered Stent.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2017 | 01:24pm CEST

April 21, 2017
London, UK

Getinge is proud to announce the launch of the Advanta™ V12™ 32mm length* balloon expandable covered stent at Charing Cross International Congress. This is a much needed addition to the Advanta™ V12™ product offering and will allow clinicians additional treatment options for optimal patient outcomes.

With over 200 clinical publications and close to 500,000 patients successfully treated worldwide, this latest product line extension will add to the rapidly growing body of evidence supporting the safety and efficacy of Getinge's covered stent technology.

The Advanta™ V12™ covered stent is a low profile, pre-mounted balloon expandable covered stent made of a radial expandable 316L stainless steel that is completely encapsulated with a patented one-piece PTFE covering technology.  Getinge's proprietary covering technology creates a microporous PTFE layer that completely encapsulates the stainless steel stent and allows for uniform expansion without ridges or folds in the material being formed.  V12 is customizable with the ability to post dilate to meet each patients anatomical needs. 

Getinge will also host, at Charing Cross, in partnership with VASCULAR INTERNATIONAL, a series of masterclass workshops in which participants will have hands-on experience using the new Advanta™ V12™ 32mm and learn the latest techniques from the experts. `It is extremely important to provide appropriate training and guidance to the medical community and these workshops allow not only hands-on experience on training models but also provide the participants with the opportunity to network and build relationships with medical experts" says Markus Stirner-Schilling, Vice President, Marketing & Academy, Getinge, Europe, Middle East & Africa.

Getinge will also support two very important satellite symposia with a focus on Advanta™ V12™ and new INTERGARD SYNERGY data.

*32mm lengths not available in all regions

About Getinge at Charing Cross:

Registered visitors are invited to visit Getinge on booth 170 from 25-28 April 2017, Olympia Grand, London, UK.

For further information, please contact

Tracey Dawe
Director Communications and Congress Management Europe, Middle East & Africa
Phone: + 44 77 177 84965
Email: [email protected]

About Getinge

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.

http://news.cision.com/getinge/r/getinge-launches-the-new-advanta-v12---32mm-balloon-expandable-covered-stent-,c2244699

http://mb.cision.com/Main/942/2244699/660959.pdf

(c) 2017 Cision. All rights reserved., source Press Releases - English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518832


Varnish cache server

Latest news on GETINGE AB
04/26 GETINGE : Sources Sought - Parts for Steam Sterilizer (Getinge)
04/26 GETINGE : Sources Sought Notice - 65-- Parts for Steam Sterilizer (Getinge)
04/21 GETINGE : launches the new Advanta V12 - 32mm Balloon Expandable Covered Stent.
04/20 GETINGE : Chief Financial Officer leaves Getinge
04/18 MEDTRONIC : Extracorporeal Membrane Oxygenation (ECMO) Systems Market 2017 - Ori..
04/12 GETINGE : announces date of 2017 Q1 report and conference call
03/30 GETINGE AB : ex-dividend day for annual dividend
03/29 GETINGE : Resolutions at Getinge’s Annual General Meeting 2017
03/29 GETINGE : Resolutions at Getinge's Annual General Meeting 2017
03/27 GETINGE : establishes new brand structure and becomes a single brand company
More news
Sector news : Medical Equipment
04/24DJWHAT'S NEWS : Business & Finance -- WSJ
04/24 Becton Dickinson to acquire Bard for $24 billion
04/23DJBECTON DICKINSON AND : to Acquire C.R. Bard for $24 Billion
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
More sector news : Medical Equipment
News from SeekingAlpha
04/25 Getinge Industrier's (GNGBF) CEO Mattias Perjos on Q1 2017 Results - Earnings..
04/25 Getinge Industrier AB reports Q1 results
01/26 Getinge Industrier's (GNGBF) CEO Joacim Lindoff on Q4 2016 Results - Earnings..
01/26 Getinge Industrier AB 2016 Q4 - Results - Earnings Call Slides
01/26 Getinge Industrier AB ADR reports Q4 results
Advertisement
Financials ( SEK)
Sales 2017 30 442 M
EBIT 2017 3 872 M
Net income 2017 2 027 M
Debt 2017 20 801 M
Yield 2017 1,73%
P/E ratio 2017 20,06
P/E ratio 2018 15,08
EV / Sales 2017 1,94x
EV / Sales 2018 1,83x
Capitalization 38 117 M
More Financials
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | GETI B | SE0000202624 | 4-Traders
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 163  SEK
Spread / Average Target -4,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Karl Joacim Claesson Lindoff President & Chief Executive Officer
Carl Reinhold Adolf Bennet Chairman
Reinhard Mayer Chief Financial Officer
Johan Malmquist Director
Johan Bygge Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GETINGE AB16.29%4 310
MASIMO CORPORATION51.13%5 242
JIANGSU YUYUE MDCL EQP..--.--%3 291
PENUMBRA INC34.87%2 894
ASAHI INTECC CO., LTD.3.45%2 804
BIOCARTIS GROUP-4.38%508
More Results
503 Backend fetch failed

Error 503 Backend fetch failed

Backend fetch failed

Guru Meditation:

XID: 98518834


Varnish cache server